Form D · Biotechnology
ELEVATION PHARMACEUTICALS INC
San Diego, CA · CIK 0001459677
Offering snapshot reported Dec 20, 2011 · SEC filing
- Reported sold
- $12.4M Offering amount: $30M
- Investors reported
- 6 Form D · investor count
- Minimum accepted
- $1 Reported outside-investor minimum
- First sale
- Dec 16, 2011 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Dec 20, 2011 | Initial | $12,400,001 | No comparison | 6 | SEC filing |
| Jan 26, 2010 | Initial | $14,957,529 | No comparison | 28 | SEC filing |
| Mar 12, 2009 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-170386
Source: Form D, filed Dec 20, 2011. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Brenton K. Ahrens | Director |
| Cam L. Garner | Director, Executive |
| William M. Gerhart | Director, Executive |
| Jan Leschly | Director |
| Heath Lukatch | Director |
| Heather Preston, M.D. | Director |
| Jaisim Shah | Executive |
| Pravin Soni, Ph.D. | Executive |
| Ahmet Tutuncu, M.D., Ph.D. | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
11455 El Camino Real Suite 460
San Diego, CA, 92130
San Diego, CA, 92130